Updated: May 19, 2026

Alfred Sandrock

VYGRVoyager Therapeutics, Inc.SEC CIK: 0001577061
Estimated Net Worth
$29.4 Million0.0%vs Last Year
Last Updated: May 19, 2026 11:40 PM EST

Transaction Summary

Total Transactions70
Buy-Sell Ratio0.00
Buy Transactions0
Sell Transactions35

Transaction Volume

Total Volume-$18.77M
Net Volume$18.77M
Buy Volume$0.00
Sell Volume-$18.77M

Trade Analysis

AVG Trade Size-$369.02K
Largest Trade$0.00
Most Active MonthFeb
Most Active Year2015

Trading Sentiment

OverallBullish
Recent TradeSelling
Last 90 Days-1 Trades
ConvictionMedium

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Alfred Sandrock has an estimated net worth of $29.4 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., NEUROCRINE BIOSCIENCES INC, and Voyager Therapeutics, Inc..



2014 was Alfred Sandrock's most active year for acquiring shares with 7 total transactions. Alfred Sandrock's most active month to acquire stocks was the month of January. 2015 was Alfred Sandrock's most active year for disposing of shares, totalling 24 transactions. Alfred Sandrock's most active month to dispose stocks was the month of January. 2013 saw Alfred Sandrock paying a total of $1,397,779.80 for 24,850 shares, this is the most they've acquired in one year. In 2013 Alfred Sandrock cashed out on 50,533 shares for a total of $6,355,832.06, their largest year based on trade value.

Holdings & Transactions

VYGRvoyager therapeutics, inc.
President and CEO Director
Updated: Apr 03, 2026VIEW QUOTE
Form TypeSEC Filing
-0.0211.51K$3.87-$44.55K472.55KScheduledApr 02View
-0.0314.20K$3.79-$53.81K484.06KScheduledFeb 24View
-0.0211.73K$3.41-$40.01K498.26KScheduledFeb 18View
-0.0212.19K$3.78-$46.09K509.99KFeb 10View
1.12488.75K924.68KFeb 06View
-0.0210.88K$3.43-$37.34K430.93KApr 02View
1.37423.30K$4.24-$49.62K731.82KFeb 20 - 21View
-0.0516.64K$4.45-$74.07K308.52KFeb 11View
-0.0412.12K$9.86-$119.45K322.84KApr 02View
-0.0413.03K$7.46-$97.23K334.95KFeb 21View
1.79390.00K607.99KFeb 09View
-0.037.44K$7.83-$58.23K214.62KApr 03View
3.53360.00K462.06KFeb 17View
1.04M1.04MMar 22View
44.00K44.00KFeb 07View
View
BIIBbiogen inc.
Head Research & Development Officer
Updated: Jun 09, 2021VIEW QUOTE
Form TypeSEC Filing
-0.437.67K$440.00-$3.38M10.17KScheduledJun 07View
14.50K14.50KFeb 18View
-0.249.28K$278.03-$975.89K29.23KFeb 12View
0.293.73K16.79KJan 27View
-0.101.50K$350.00-$525.00K13.07KScheduledNov 04View
-0.091.45K$333.00-$179.15K14.48KFeb 15View
0.246.96K$331.76-$630.68K35.52KFeb 12View
-0.131.56K$325.33-$240.42K10.41KFeb 22View
-0.111.39K$332.87-$195.06K11.61KFeb 15View
0.245.17K$319.43-$804.32K26.82KFeb 12View
-0.04259.00$290.83-$75.32K6.55KScheduledFeb 27View
-0.201.71K$293.32-$327.34K6.81KScheduledFeb 23View
-0.141.57K$284.81-$207.06K9.94KFeb 22View
-0.10743.00$292.00-$216.96K6.55KScheduledFeb 20View
-0.151.29K$298.85-$386.71K7.30KScheduledFeb 15View
-0.101.38K$299.38-$178.43K12.84KFeb 15View
0.648.89K$316.63-$416.69K22.87KFeb 12View
-0.221.98K$274.08-$542.95K7.06KScheduledApr 03View
-0.10973.00$290.07-$282.24K9.04KScheduledMar 01View
-0.247.33K$278.17-$829.22K22.86KFeb 28View
6.38K6.38KFeb 15View
-0.02183.00$261.90-$47.93K7.99KScheduledFeb 25View
-0.08853.00$258.99-$42.47K10.25KFeb 23View
7.27K7.27KFeb 22View
-0.08722.00$256.16-$184.95K7.99KScheduledFeb 17View
-0.164.49K$247.22-$451.67K22.95KFeb 12View
-0.141.28K$247.95-$316.88K7.74KScheduledFeb 08 - 09View
-0.10834.00$276.26-$230.40K7.74KScheduledDec 03 - 04View
-0.05430.00$430.12-$184.95K8.57KScheduledMar 27View
-0.406.00K$409.54-$2.46M9.00KScheduledMar 01 - 02View
3.11K3.11KFeb 23View
-0.03418.00$389.11-$162.65K15.00KScheduledFeb 17View
-0.061.28K$392.11-$296.83K19.68KFeb 12View
-0.071.14K$398.11-$455.04K14.57KScheduledFeb 10View
-0.101.96K$398.49-$780.25K17.00KScheduledFeb 08 - 09View
-0.05833.00$346.57-$288.69K14.57KScheduledDec 03 - 04View
-0.173.17K$342.58-$1.09M15.41KScheduledMar 04View
-0.132.83K$340.68-$963.78K18.58KMar 03View
-0.051.05K$342.17-$358.59K21.41KScheduledFeb 26View
-0.04940.00$347.11-$326.28K22.46KFeb 23View
1.4424.29K$319.49-$253.03K41.13KScheduledFeb 12 - 13View
-0.132.08K$314.31-$655.34K13.67KScheduledFeb 11View
-0.051.02K$315.54-$320.59K20.13KFeb 08 - 09View
-0.06833.00$286.78-$238.89K13.67KScheduledDec 03 - 04View
-0.5115.03K$155.34-$2.85M14.50KScheduledOct 22View
-0.409.82K$144.88-$1.87M14.50KScheduledSep 16View
From 3/AView
14.50KView
NBIXneurocrine biosciences inc
Updated: May 23, 2019VIEW QUOTE
Form TypeSEC Filing
10.00K10.00KMay 22View
12.50K12.50KMay 24View
15.00K15.00KMay 22View
15.00K15.00KMay 20View
40.00K40.00KSep 02View
View